Drug intelligence / Profile preview

TC-3

Development stage
Unknown
Lead developer
UroGen Pharma
Modality
Hydrogel Systems → Drug Delivery Systems
Administration
Intravesical Instillation
01

Overview

TC-3 is a proprietary reverse thermal biodegradable hydrogel developed by UroGen Pharma (formerly TheraCoat Ltd.). It is designed as a drug delivery system for intravesical administration, primarily in the urinary bladder. The hydrogel is characterized by its ability to remain in a liquid state at cold temperatures (5°C) and transition into a solid gel upon reaching body temperature. This property allows it to form a localized drug reservoir within the bladder, facilitating the sustained release and prolonged contact of co-administered active pharmaceutical ingredients, such as Mitomycin C (MMC) or Botulinum Toxin A (BTX), with the bladder urothelium. This extended exposure aims to enhance the therapeutic efficacy and duration of treatment for various urological conditions.

Brand names
TheraCoat

Beyond the preview

Go deeper on TC-3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TC-3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call